TABLE 1.
Clinical and pathologic characteristics of 35 patients who underwent liver resection for metastatic melanoma
| Characteristic | Value |
|---|---|
| Feature | |
| Age, median (range) at diagnosis (y) | 41 (17–60) |
| Age, median (range) at operation (y) | 44 (26–66) |
| Sex, M/F | 24/11 |
| AJCC stage, n (%) | |
| I/II | 12 (35%) |
| III | 16 (47%) |
| IV | 5 (15%) |
| Unknown | 1 (3%) |
| Pathology, n (%) | |
| Cutaneous | 29 (83%) |
| Ocular | 1 (3%) |
| Unknown primary | 5 (14%) |
| DFI | |
| DFI-1 (mo), median (range) | 17 (0–124) |
| DFI-2 (mo), median (range) | 0 (0–76) |
| Hepatic resection, n (%) | |
| Nonanatomic resection | 10 (29%) |
| Anatomic resection | 25 (71%) |
| Laparoscopic | 10 (29%) |
| Open | 25 (71%) |
| Left lateral sectionectomy | 5 (14%) |
| Wedge resection | 8 (23%) |
| Segmentectomy | 13 (37%) |
| Left hepatectomy | 2 (6%) |
| Left trisectionectomy | 1 (3%) |
| Right hepatectomy | 3 (9%) |
| Bisegmentectomy | 2 (6%) |
| Posterior sectionectomy | 1 (3%) |
| Reoperation | 3 (9%) |
| No. of metastases, n (%) | |
| 1 | 15 (43%) |
| 2 | 1 (3%) |
| >2 | 19 (54%) |
| Synchronous extrahepatic metastases, n (%) | 24 (69%) |
| Free of disease after resection, n (%) | 11 (31%) |
AJCC American Joint Committee on Cancer, DFI disease-free interval